Yemaachi Biotechnology
ActiveDiversifying precision cancer diagnostics and treatments
What it does
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
Its site says now · captured 2026-08-23
Yemaachi Biotech – Cancer Innovation Shaped by Africa
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in diverse populations.
Next to it in Healthcare and bio · precision cancer diagnostics Africa
- Signatur BiosciencesY Combinator S22
Simple tests for complex diseases.
- AOA DxY Combinator S21
Blood Test for Early Detection of Ovarian Cancer
- NearWaveY Combinator W22
Helping physicians select the right therapy for breast cancer patients
- CrosscopeTechstars TS 2020
Crosscope | Next Generation Pathology
- NumenY Combinator S23
Engineering a future without cancer deaths.
- Data Driven BioscienceY Combinator S18
Cancer Diagnosis 10X faster, 10X cheaper
- Asima Health Inc.Plug and Play PnP 2024
World's fastest, simplest and cheapest pan-cancer screening platform.
- NeurodeSOSV SOSV HAX 2021
Changing the way we treat ADHD